Core Viewpoint - Donghua Software's stock has experienced fluctuations, with a recent decline of 2.09% and a year-to-date increase of 7.43%, indicating volatility in its market performance [1]. Financial Performance - For the period from January to September 2025, Donghua Software reported a revenue of 8.488 billion yuan, reflecting a year-on-year growth of 3.69%. However, the net profit attributable to shareholders decreased by 28.45% to 350 million yuan [2]. - Cumulatively, since its A-share listing, Donghua Software has distributed a total of 2.826 billion yuan in dividends, with 481 million yuan distributed over the past three years [3]. Shareholder and Market Activity - As of September 30, 2025, the number of shareholders for Donghua Software was 315,200, a decrease of 2.68% from the previous period. The average number of circulating shares per person increased by 2.76% to 9,226 shares [2]. - The stock's trading activity showed a net outflow of 51.01 million yuan from major funds, with significant buying and selling activity recorded [1]. Company Overview - Donghua Software, established in January 2001 and listed in August 2006, is primarily engaged in industry application software development, computer information system integration, and related services. Its revenue composition includes 68.15% from system integration, 17.71% from technical services, and 14.09% from software sales [1]. - The company operates within the computer-IT services sector and is associated with various concept sectors, including IPV6, knowledge payment, DRG concept, digital economy, and AI applications in healthcare [1]. Institutional Holdings - As of September 30, 2025, notable institutional shareholders include Huabao Zhongzheng Financial Technology Theme ETF, holding 36.935 million shares, and Southern Zhongzheng 500 ETF, holding 32.659 million shares, with varying changes in their holdings compared to the previous period [3].

Core Viewpoint - The stock price of Weining Health has shown significant volatility, with a year-to-date increase of 34.92% but a recent decline of 14.88% over the past five trading days [2]. Group 1: Stock Performance - As of January 20, Weining Health's stock price reached 11.90 CNY per share, with a trading volume of 1.216 billion CNY and a turnover rate of 5.68%, resulting in a total market capitalization of 26.365 billion CNY [1]. - The stock has experienced a 29.63% increase over the past 20 days and a 36.00% increase over the past 60 days [2]. Group 2: Financial Performance - For the period from January to September 2025, Weining Health reported a revenue of 1.296 billion CNY, representing a year-on-year decrease of 32.27%, and a net profit attributable to shareholders of -241 million CNY, a decline of 256.10% [2]. - The company has distributed a total of 455 million CNY in dividends since its A-share listing, with 97.226 million CNY distributed over the past three years [3]. Group 3: Shareholder Information - As of January 9, 2025, the number of Weining Health's shareholders was 117,900, a decrease of 0.61% from the previous period, with an average of 15,467 circulating shares per shareholder, an increase of 0.62% [2]. - The top ten circulating shareholders include notable funds such as Huabao Zhongzheng Medical ETF and E Fund Growth Mixed A, with some shareholders reducing their holdings [3]. Group 4: Business Overview - Weining Health, established on April 7, 2004, and listed on August 18, 2011, specializes in the research, development, sales, and technical services of medical software, providing comprehensive solutions for healthcare information technology [2]. - The company's revenue composition includes 84.65% from software and services, 7.89% from hardware sales, and 7.46% from internet healthcare [2].

Core Viewpoint - JiuYuan YinHai's stock price has shown significant growth in recent months, with a year-to-date increase of 22.85% and a recent 20-day increase of 26.74% [1] Group 1: Stock Performance - On January 16, JiuYuan YinHai's stock price fell by 3.04%, trading at 22.04 CNY per share with a total market capitalization of 8.997 billion CNY [1] - The stock has experienced a trading volume of 1.58 billion CNY and a turnover rate of 1.78% [1] - The net outflow of main funds was 16.1873 million CNY, with large orders showing a buy of 26.2079 million CNY and a sell of 30.5548 million CNY [1] Group 2: Financial Performance - For the period from January to September 2025, JiuYuan YinHai reported a revenue of 687 million CNY, reflecting a year-on-year growth of 2.83% [2] - The net profit attributable to shareholders reached 42.7891 million CNY, marking a substantial increase of 127.43% year-on-year [2] Group 3: Shareholder Information - As of November 28, the number of shareholders for JiuYuan YinHai was 55,600, a decrease of 0.93% from the previous period [2] - The average number of circulating shares per shareholder increased by 0.94% to 7,280 shares [2] - The company has distributed a total of 472 million CNY in dividends since its A-share listing, with 151 million CNY distributed over the last three years [3]

Core Viewpoint - Donghua Software's stock has shown a mixed performance in recent trading sessions, with a year-to-date increase of 5.36% but a decline over the past 60 days of 8.19% [1] Group 1: Stock Performance - On January 8, Donghua Software's stock rose by 2.23%, reaching 9.64 CNY per share, with a trading volume of 316 million CNY and a turnover rate of 1.14% [1] - The stock has experienced a net inflow of main funds amounting to 36.61 million CNY, with significant buying from large orders [1] - Over the last five trading days, the stock has increased by 6.05%, while it has decreased by 3.50% over the last 20 days [1] Group 2: Financial Performance - For the period from January to September 2025, Donghua Software reported a revenue of 8.488 billion CNY, reflecting a year-on-year growth of 3.69% [2] - The net profit attributable to shareholders for the same period was 350 million CNY, which represents a year-on-year decrease of 28.45% [2] Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Donghua Software was 315,200, a decrease of 2.68% from the previous period [2] - The average number of circulating shares per shareholder increased by 2.76% to 9,226 shares [2] Group 4: Dividend and Institutional Holdings - Donghua Software has distributed a total of 2.826 billion CNY in dividends since its A-share listing, with 481 million CNY distributed over the last three years [3] - Among the top ten circulating shareholders, Huabao Zhongzheng Financial Technology Theme ETF holds 36.935 million shares, an increase of 18.136 million shares from the previous period [3]

机构持仓方面，截止2025年9月30日，久远银海十大流通股东中，香港中央结算有限公司位居第三大流 通股东，持股305.37万股，相比上期减少156.95万股。金鹰科技创新股票A（001167）位居第四大流通 股东，持股300.00万股，为新进股东。南方中证1000ETF（512100）位居第六大流通股东，持股261.78 万股，相比上期减少1.61万股。易方达新常态混合（001184）退出十大流通股东之列。 责任编辑：小浪快报 1月5日，久远银海盘中上涨2.06%，截至13:43，报18.31元/股，成交9938.23万元，换手率1.36%，总市 值74.75亿元。 资金流向方面，主力资金净流入348.60万元，特大单买入845.32万元，占比8.51%，卖出294.23万元，占 比2.96%；大单买入1119.35万元，占比11.26%，卖出1321.84万元，占比13.30%。 截至11月28日，久远银海股东户数5.56万，较上期减少0.93%；人均流通股7280股，较上期增加0.94%。 2025年1月-9月，久远银海实现营业收入6.87亿元，同比增长2.83%；归母净利润4278.91万元，同比增长 ...

Group 1 - The core viewpoint of the news is that Neusoft Corporation's stock has shown fluctuations, with a recent increase of 2.12% and a total market capitalization of 12.066 billion yuan [1] - As of December 31, Neusoft's stock price is 10.12 yuan per share, with a trading volume of 139 million yuan and a turnover rate of 1.16% [1] - Year-to-date, Neusoft's stock has decreased by 4.71%, with a recent 5-day increase of 2.02% and a 20-day increase of 0.60% [1] Group 2 - Neusoft's main business includes software technology, industry solutions, software products, platforms, services, and medical equipment, with 85.92% of revenue from proprietary software, products, and services [1] - As of September 30, Neusoft's revenue for the first nine months of 2025 was 7.491 billion yuan, a year-on-year increase of 8.72%, while net profit attributable to shareholders was 51.0818 million yuan, a decrease of 66.47% [2] - The company has distributed a total of 1.894 billion yuan in dividends since its A-share listing, with 332 million yuan distributed in the last three years [3] Group 3 - Neusoft's stockholder count reached 98,200 as of September 30, 2025, an increase of 8.72% from the previous period, while the average circulating shares per person decreased by 9.15% to 12,145 shares [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, holding 23.2244 million shares, a decrease of 21.662 million shares from the previous period [3]

Core Viewpoint - Neusoft Corporation's stock price has shown fluctuations, with a recent increase of 2.45% to 10.03 CNY per share, while the company has experienced a year-to-date decline of 5.56% [1] Financial Performance - For the period from January to September 2025, Neusoft Corporation achieved a revenue of 7.491 billion CNY, representing a year-on-year growth of 8.72%. However, the net profit attributable to shareholders decreased by 66.47% to 51.0818 million CNY [2] - The company has cumulatively distributed 1.894 billion CNY in dividends since its A-share listing, with 332 million CNY distributed over the past three years [3] Stock Market Activity - As of December 18, 2025, Neusoft's market capitalization stands at 11.959 billion CNY, with a trading volume of 101 million CNY and a turnover rate of 0.86% [1] - The stock has appeared on the "龙虎榜" (a trading board for stocks with significant trading activity) three times this year, with the latest instance on September 19, where it recorded a net buy of 1.01 billion CNY [1] Shareholder Information - As of September 30, 2025, Neusoft had 98,200 shareholders, an increase of 8.72% from the previous period, with an average of 12,145 circulating shares per shareholder, a decrease of 9.15% [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 23.2244 million shares, a decrease of 21.662 million shares from the previous period [3]

Core Viewpoint - Weining Health's stock has shown fluctuations in recent trading sessions, with a year-to-date increase of 22.74% but a decline over the last 60 days of 12.91% [1] Financial Performance - For the period from January to September 2025, Weining Health reported a revenue of 1.296 billion yuan, a year-on-year decrease of 32.27%, and a net profit attributable to shareholders of -241 million yuan, reflecting a significant decline of 256.10% [2] - Cumulative cash dividends since the A-share listing amount to 455 million yuan, with 97.226 million yuan distributed over the last three years [3] Shareholder Structure - As of November 20, 2025, the number of Weining Health's shareholders decreased by 1.51% to 112,400, while the average circulating shares per person increased by 1.53% to 17,039 shares [2] - The top ten circulating shareholders include notable funds such as Huabao Zhongzheng Medical ETF and Yifangda Growth Mixed A, with some shareholders reducing their stakes [3] Stock Market Activity - On December 1, Weining Health's stock price reached 8.77 yuan per share, with a trading volume of 312 million yuan and a turnover rate of 1.89% [1] - The stock has appeared on the "Dragon and Tiger List" twice this year, with the most recent occurrence on February 7 [1] Business Overview - Weining Health, established on April 7, 2004, and listed on August 18, 2011, specializes in medical software development, sales, and technical services, providing comprehensive solutions for the healthcare industry's information technology needs [1] - The company's revenue composition includes 84.65% from software and services, 7.89% from hardware sales, and 7.46% from internet healthcare [1] Industry Classification - Weining Health is classified under the Shenwan industry category of Computer-Software Development-Vertical Application Software, and is associated with concepts such as AI models, domestic software, Alibaba Cloud, and DRG concepts [1]

Group 1 - The core viewpoint of the news is that 思创医惠's stock has experienced fluctuations, with a recent decline of 2.20% and a total market value of 4.45 yuan per share, amounting to 49.75 billion yuan [1] - The company has seen a year-to-date stock price increase of 46.38%, but a recent decline of 8.81% over the last five trading days [1] - The company has been listed on the龙虎榜 five times this year, with the most recent occurrence on November 19 [1] Group 2 - As of September 30, the number of shareholders for 思创医惠 is 58,400, a decrease of 11.34% from the previous period [2] - For the period from January to September 2025, the company achieved a revenue of 604 million yuan, representing a year-on-year growth of 6.95% [2] - The company reported a net profit attributable to shareholders of -4.76 million yuan, showing a year-on-year increase of 98.32% [2] Group 3 - Since its A-share listing, 思创医惠 has distributed a total of 532 million yuan in dividends, with no dividends paid in the last three years [3]

Core Viewpoint - The stock price of Sichuang Medical has increased significantly this year, with a notable rise in recent trading days, indicating strong market interest and potential growth in the healthcare technology sector [2]. Group 1: Stock Performance - Sichuang Medical's stock price has risen by 54.61% year-to-date, with a 4.21% increase in the last five trading days, a 32.02% increase over the last 20 days, and a 27.37% increase over the last 60 days [2]. - The company has appeared on the stock market's "Dragon and Tiger List" five times this year, with the most recent appearance on November 19 [2]. Group 2: Company Overview - Sichuang Medical, established on November 21, 2003, and listed on April 30, 2010, is based in Hangzhou, Zhejiang Province, and focuses on smart hospital solutions, disease research management, and AI services in healthcare [2]. - The company's revenue composition includes 53.84% from real estate sales, 39.28% from business intelligence, and 6.87% from smart healthcare [2]. - Sichuang Medical is classified under the computer-IT services industry and is associated with various concepts such as DRG, family doctor, and new retail [2]. Group 3: Financial Performance - For the period from January to September 2025, Sichuang Medical reported a revenue of 604 million yuan, reflecting a year-on-year growth of 6.95%, while the net profit attributable to shareholders was -4.76 million yuan, showing a significant year-on-year improvement of 98.32% [2]. - As of September 30, the number of shareholders was 58,400, a decrease of 11.34% from the previous period, while the average circulating shares per person increased by 12.79% to 19,077 shares [2]. Group 4: Dividend Information - Since its A-share listing, Sichuang Medical has distributed a total of 532 million yuan in dividends, with no dividends paid in the last three years [3].